http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2476471-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee60c4283db17b2634030438db84cef7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f54743fa3e85ebcc19ab6bc1c8e8f9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_111d6d5804ced163fe474b3413ee3604
publicationDate 2011-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2476471-A
titleOfInvention Cotinine formulation for the treatment of obesity
abstract A liquid formulation comprises at least one pharmaceutically active agent selected fromcotinine,myosmine,nicotinen-oxide,anatabineornicotyrine. The formulation is useful in the treatment or prophylaxis of obesity of overweight and as an appetite suppressant. Preferably the composition is provided as a spray or aerosol formulation, in particular, for oral or sub-lingual administration. The formulation may further include carriers such as alkyl alcohols preferably ethanol, propellants and a flaouring oil such as orange oil to enhance the functional properties and improve absorption. A composition comprising a cotinine solution of a lower alcohol or polyol, a propellant and flavouring oil is provided. A device for providing pharmaceutical doses comprising the formulation and a valve means arranged for delivering aerosol doses is also outlined.
priorityDate 2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9529676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9915171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007093796-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008103818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007118653-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID854019
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414867949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13129
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415877326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522605
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408332741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID211457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10249

Total number of triples: 40.